Manchester Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Manchester Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$14K	–	525
2016 Q3	$14K	Hold	1,000	–	–	﹤0.01%	439
2016 Q2	$7K	Hold	1,000	–	–	﹤0.01%	482
2016 Q1	$6K	Hold	1,000	–	–	﹤0.01%	544
2015 Q4	$6K	Hold	1,000	–	–	﹤0.01%	618
2015 Q3	$6K	Hold	1,000	–	–	﹤0.01%	598
2015 Q2	$8K	Hold	1,000	–	–	﹤0.01%	514
2015 Q1	$8K	Hold	1,000	–	–	﹤0.01%	505
2014 Q4	$7K	Hold	1,000	–	–	﹤0.01%	1021
2014 Q3	$5K	Hold	1,000	–	–	﹤0.01%	1025
2014 Q2	$6K	Hold	1,000	–	–	﹤0.01%	1009
2014 Q1	$8K	Hold	1,000	–	–	﹤0.01%	880
2013 Q4	$7K	Sell	1,000 -11,899	-92%	-$64.2K	﹤0.01%	832
2013 Q3	$237K	Hold	12,899	–	–	0.04%	293
2013 Q2	$226K	Buy	+12,899	New	+$229K	0.04%	276

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Manchester Capital Management's ARIA Position: Q4 2016 in Review

Manchester Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 1,000 shares — an estimated $14K sold.

Manchester Capital Management first reported a position in ARIA in Q2 2013 and held it in 14 quarters. The position peaked at $237K in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

Manchester Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Manchester Capital Management sold 1,000 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $14K.
Manchester Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
Manchester Capital Management's Ariad Pharmaceuticals Inc position peaked at $237K in Q3 2013.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Manchester Capital Management's 13F filing for Q4 2016, filed 6 Feb 2017.